MicroPort Endovascular MedTech Ltd (688016) — Capital Reinvestment Ratio
MicroPort Endovascular MedTech Ltd (688016) has a Capital Reinvestment Ratio of 1.84x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥46.79 Million) in capital expenditures (CN¥86.03 Million). See 688016 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
MicroPort Endovascular MedTech Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks MicroPort Endovascular MedTech Ltd's Capital Reinvestment Ratio across 10 annual periods. Check MicroPort Endovascular MedTech Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for MicroPort Endovascular MedTech Ltd from 2016 to 2025. For live market cap and broader valuation context, see market cap of MicroPort Endovascular MedTech Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | CN¥573.06 Million | CN¥303.03 Million | ▼ -7.1% |
| 2024 | 0.57x | CN¥373.60 Million | CN¥212.65 Million | ▲ +70.9% |
| 2023 | 0.33x | CN¥571.22 Million | CN¥190.26 Million | ▼ -62.2% |
| 2022 | 0.88x | CN¥333.76 Million | CN¥293.98 Million | ▲ +195.2% |
| 2021 | 0.30x | CN¥300.25 Million | CN¥89.58 Million | ▲ +147.4% |
| 2020 | 0.12x | CN¥217.44 Million | CN¥26.22 Million | ▼ -18.7% |
| 2019 | 0.15x | CN¥143.20 Million | CN¥21.24 Million | ▼ -36.4% |
| 2018 | 0.23x | CN¥106.85 Million | CN¥24.90 Million | ▼ -42.7% |
| 2017 | 0.41x | CN¥69.36 Million | CN¥28.23 Million | ▼ -61.4% |
| 2016 | 1.06x | CN¥30.13 Million | CN¥31.81 Million | — |